Security key
426897401
Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA)
CUSIP: 426897401
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 17,361
- Total 13F value
- $1,389
- Share change
- -959,001
- SEC-reported price per share
- $0.08
- Number of holders
- 1
- Value change
- -$418,305
- Number of buys
- 1
- Number of sells
- 13
- Shares outstanding
- 92,105,263
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
1
Top holders
1
HEPA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Hepion Pharmaceuticals, Inc. SEC filings
Hepion Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 426897401
Recent filing periods:
Ownership snapshot
Top reported holders of HEPA - Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BIGGER CAPITAL FUND L P
Disclosed value leader
SABBY MANAGEMENT, LLC
Comparable rows
14/15
Latest evidence
31 Mar 2025
13D/G
13F
3/4/5
Lead comparable stake: 10%
1 rows are not safely comparable across share classes.
13D/G row: BIGGER CAPITAL FUND L P
Showing 1-6 of 15 holder rows.
Quick read
BIGGER CAPITAL FUND L P leads the comparable SEC ownership view at 10%.
14 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BIGGER CAPITAL FUND L P's linked filing trail.
Comparable ownership
Top 5
BIGGER CAPITAL FUND L P
10%
Anson Funds Management LP
4.9%
SABBY MANAGEMENT, LLC
0.91%
HRT FINANCIAL LP
0.02%
CITADEL ADVISORS LLC
0.02%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BIGGER CAPITAL FUND L P |
13D/G
|
10%
|
$21,218
1,060,883 shares
|
$0 | 21 Jan 2025 |
| Anson Funds Management LP |
13F
13D/G
Company
|
4.9%
from 13D/G
|
$45,434
105,685 shares
|
— | 31 Mar 2025 |
| SABBY MANAGEMENT, LLC |
13F
Company
|
0.91%
|
$359,661
836,615 shares
|
— | 31 Mar 2025 |
| HRT FINANCIAL LP |
13F
Company
|
0.02%
|
$7,000
16,387 shares
|
— | 31 Mar 2025 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.02%
|
$6,698
15,581 shares
|
— | 31 Mar 2025 |
| BlackRock, Inc. |
13F
Company
|
0%
|
$713
1,658 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
17,361
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
13
Q2 2025 holders
1
Holder diff
-12
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend